How much cash does eXoZymes Inc. Common Stock generate?

eXoZymes Inc. Common Stock (EXOZ) generated -$6.9M in operating cash flow over the trailing twelve months.

What is eXoZymes Inc. Common Stock's free cash flow?

After $196.5K of capital expenditures, eXoZymes Inc. Common Stock's free cash flow was -$7.1M over the trailing twelve months, up 30.5% year over year.

Where does eXoZymes Inc. Common Stock's cash flow data come from?

Every line is extracted from eXoZymes Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

eXoZymes Inc. Common Stock EXOZ Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	-$9.67M-5.6%	-$9.16M-9.8%	-$8.34M-8.2%	-$7.71M-14.9%	-$6.71M-14.5%
Depreciation and amortization	$291.61K+1.3%	$287.96K+2.1%	$281.93K+1.0%	$279.2K+1.5%	$275.09K+2.9%
Stock-based compensation	$2.17M+9.2%	$1.99M+22.2%	$1.63M+7.1%	$1.52M+16.8%	$1.3M+15.5%
Change in accounts receivable	——	——	——	——	——
Change in accounts payable	——	——	——	——	$315.12K+42.4%
Change in other assets	$30.34K+58.9%	$19.1K+144%	-$43.64K-158%	$75.23K+976%	-$8.58K-109%
Net cash from operating activities	-$6.89M-6.0%	-$6.5M+36.5%	-$10.24M-14.7%	-$8.92M+10.1%	-$9.92M-16.6%
Capital expenditures	$196.48K+15.6%	$169.92K-44.4%	$305.34K+4.6%	$292.03K+4.8%	$278.69K-29.7%
Net cash from investing activities	-$176.78K-17.7%	-$150.22K+47.4%	-$285.64K-4.9%	-$272.33K+2.3%	-$278.69K+28.6%
Proceeds from issuance of common stock	——	——	——	——	——
Payments for finance leases	——	——	——	——	——
Net cash from financing activities	——	——	——	——	$18.57M+0.3%
Net increase (decrease) in cash	-$7.07M-5.8%	-$6.68M-237%	$4.86M-28.7%	$6.83M-18.7%	$8.4M-13.0%
Interest paid	——	——	——	——	——
Amortization	-$51.45K+2.8%	-$52.91K+1.4%	-$53.67K+2.5%	-$55.07K-0.8%	-$54.64K-0.5%
Change In Fair Value Of Simple Agreement For Future Equity	——	——	——	——	——
Depreciation	$291.61K+1.3%	$287.96K+2.1%	$281.93K+1.0%	$279.2K+1.5%	$275.09K+2.9%
Increase (Decrease) in Accounts Payable and Other Operating Liabilities	——	——	——	——	$315.12K+42.4%
Increase Decrease In Due To Related Parties	——	——	——	——	——
Increase (Decrease) in Prepaid Expense and Other Assets	$30.34K+58.9%	$19.1K+144%	-$43.64K-158%	$75.23K+976%	-$8.58K-109%
Finance Lease, Principal Payments	——	——	——	——	——
Cash repayments to related parties – net	——	——	——	——	——
Conversion Of Safe Note To Common Shares	——	——	——	——	——
Operating Lease Expense	——	——	——	——	——
Proceeds From Issuance Of Warrants	——	——	——	——	——
Related Party Debt Forgiveness	——	$147.1K—	——	——	——
Rightofuse Assets Obtained In Exchange For New Lease Liabilities	——	$136.39K—	——	——	——
Free cash flow	-$7.09M-6.3%	-$6.67M+36.7%	-$10.54M-14.4%	-$9.21M+9.7%	-$10.2M-14.6%
Free cash flow	-$7.09M-6.3%	-$6.67M+36.7%	-$10.54M-14.4%	-$9.21M+9.7%	-$10.2M-14.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about eXoZymes Inc. Common Stock.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does eXoZymes Inc. Common Stock generate?: eXoZymes Inc. Common Stock (EXOZ) generated -$6.9M in operating cash flow over the trailing twelve months.
What is eXoZymes Inc. Common Stock's free cash flow?: After $196.5K of capital expenditures, eXoZymes Inc. Common Stock's free cash flow was -$7.1M over the trailing twelve months, up 30.5% year over year.
Where does eXoZymes Inc. Common Stock's cash flow data come from?: Every line is extracted from eXoZymes Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.